Why the study?
Aortic stenosis is associated with myocardial ischemia and may impair coronary flow, but data on the impact of moderate aortic stenosis in acute myocardial infarction are limited.
Does the presence of moderate aortic stenosis worsen clinical outcomes in patients presenting with acute myocardial infarction?
Does the presence of moderate aortic stenosis worsen clinical outcomes in patients presenting with acute myocardial infarction?
Moderate aortic stenosis in patients with acute myocardial infarction is associated with significantly higher 1-year mortality and heart failure hospitalizations.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“Moreover, current guidelines do not provide specific recommendations for the management of aortic stenosis in patients with ACS. Recent publications suggest poor survival rates in patients with isolated moderate aortic stenosis, thus potential early interventions of these patients are under study.”
May warrant heightened vigilance for moderate AS in acute MI; hypothesis-generating for intervention trials.
BACKGROUND: Aortic stenosis (AS) is associated with myocardial ischemia through different mechanisms and may impair coronary arterial flow. However, data on the impact of moderate AS in patients with acute myocardial infarction (MI) is limited. AIMS: This study aimed to investigate the impact of moderate AS in patients presenting with acute myocardial infarction (MI). METHODS: We conducted a retrospective analysis of all patients who presented with acute MI to all Mayo Clinic hospitals, using the Enterprise Mayo PCI Database from 2005 to 2016. Patients were stratified into two groups: moderate AS and mild/no AS. The primary outcome was all cause mortality. RESULTS: The moderate AS group included 183 (13.3%) patients, and the mild/no AS group included 1190 (86.7%) patients. During hospitalization, there was no difference between both groups in mortality. Patients with moderate AS had higher in-hospital congestive heart failure (CHF) (8.2% vs. 4.4%, p = 0.025) compared with mild/no AS patients. At 1-year follow-up, patients with moderate AS had higher mortality (23.9% vs. 8.1%, p < 0.001) and higher CHF hospitalization (8.3% vs. 3.7%, p = 0.028). In multivariate analysis, moderate AS was associated with higher mortality at 1-year (odds ratio 2.4, 95% confidence interval [1.4-4.1], p = 0.002). In subgroup analyses, moderate AS increased all-cause mortality in STEMI and NSTEMI patients. CONCLUSION: The presence of moderate AS in acute MI patients was associated with worse clinical outcomes during hospitalization and at 1-year follow-up. These unfavorable outcomes highlight the need for a close follow-up of these patients and for timely therapeutic strategies to best manage these coexisting conditions.
No takes yet. Share an insight, caveat, or question.
Abraham et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: